$1,370,000 of NORTHROP GRUMMAN CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"National Defense Authorization Act for Fiscal Year 2026 (S. 2296, H.R. 3838); FY2026 Defense Appropriations Act (H.R. 4016, no Senate bill number assigned); FY2026 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (H.R. 3944); One Big Beautiful Bill Act (H.R. 1); National Security Space Programs; Microelectronics; spectrum policy; Streamlining Procurement for Effective Execution and Delivery Act of 2025 (SPEED Act)(H.R. 3838); Fostering Reform and Government Efficiency in Defense Act (FoRGED Act)(S. 5618) FY2026 Defense Appropriations Act (H.R. 4016, no Senate bill number assigned); National Defense Authorization Act for Fiscal Year 2026 (S. 2296, H.R. 3838) Amortization of Qualified Research and Experimentation Expenses; Additional First-year ("Bonus") Depreciation Deduction; Corporate Statutory Rate; One Big Beautiful Bill Act (H.R. 1) Export Control Reform, Foreign Military Sales, Defense Trade, International Sales; National Defense Authorization Act for Fiscal Year 2026 ( S. 2296, H.R. 3838) National Defense Authorization Act for Fiscal Year 2026 (S. 2296, H.R. 3838); Intelligence Authorization Act for Fiscal Year 2026 (S. 2342, no House bill number assigned) Reprogrammings FY2026 Commerce Justice Science Appropriations Act (S. 2354, no House bill number assigned); NASA Transition Authorization Act of 2025 (S. 933); One Big Beautiful Bill Act (H.R. 1)"
You can find more data on corporate lobbying on Quiver Quantitative.
NOC Congressional Stock Trading
Members of Congress have traded $NOC stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $NOC stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 05/30.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NOC Insider Trading Activity
NOC insiders have traded $NOC stock on the open market 68 times in the past 6 months. Of those trades, 0 have been purchases and 68 have been sales.
Here’s a breakdown of recent trading of $NOC stock by insiders over the last 6 months:
- KATHY J WARDEN (Chair, CEO and President) has made 0 purchases and 3 sales selling 15,000 shares for an estimated $7,433,212.
- ROBERT J. FLEMING (CVP and Pres. Space Systems) sold 3,500 shares for an estimated $1,770,195
- THOMAS H JONES (CVP & Pres Aeronautics Systems) has made 0 purchases and 3 sales selling 2,187 shares for an estimated $1,101,351.
- MICHAEL A HARDESTY (Corp VP, Controller & CAO) sold 1,931 shares for an estimated $875,872
- KATHRYN G SIMPSON (Corp VP & General Counsel) has made 0 purchases and 2 sales selling 1,924 shares for an estimated $840,013.
- ROSHAN S ROEDER (CVP & Pres. Mission Systems) sold 991 shares for an estimated $485,590
- BENJAMIN R. DAVIES (CVP & Pres. Defense Systems) has made 0 purchases and 3 sales selling 949 shares for an estimated $426,658.
- MARK A III WELSH has made 0 purchases and 54 sales selling 198 shares for an estimated $96,456.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NOC Hedge Fund Activity
We have seen 732 institutional investors add shares of NOC stock to their portfolio, and 711 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 1,516,687 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $758,313,166
- WELLINGTON MANAGEMENT GROUP LLP added 974,633 shares (+23.4%) to their portfolio in Q1 2025, for an estimated $499,021,842
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 935,554 shares (+1425.2%) to their portfolio in Q1 2025, for an estimated $479,013,003
- JPMORGAN CHASE & CO removed 865,682 shares (-23.1%) from their portfolio in Q1 2025, for an estimated $443,237,840
- CAPITAL INTERNATIONAL INVESTORS added 613,621 shares (+7.4%) to their portfolio in Q1 2025, for an estimated $314,180,088
- VANGUARD GROUP INC added 588,520 shares (+4.6%) to their portfolio in Q1 2025, for an estimated $301,328,125
- AQR CAPITAL MANAGEMENT LLC added 446,940 shares (+98.8%) to their portfolio in Q1 2025, for an estimated $228,837,749
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NOC Analyst Ratings
Wall Street analysts have issued reports on $NOC in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 04/24/2025
- RBC Capital issued a "Outperform" rating on 04/23/2025
- Truist Securities issued a "Buy" rating on 04/23/2025
- Susquehanna issued a "Positive" rating on 04/23/2025
- UBS issued a "Buy" rating on 04/23/2025
- Morgan Stanley issued a "Overweight" rating on 04/16/2025
- Citigroup issued a "Buy" rating on 02/10/2025
To track analyst ratings and price targets for NOC, check out Quiver Quantitative's $NOC forecast page.
NOC Price Targets
Multiple analysts have issued price targets for $NOC recently. We have seen 9 analysts offer price targets for $NOC in the last 6 months, with a median target of $550.0.
Here are some recent targets:
- Scott Deuschle from Deutsche Bank set a target price of $542.0 on 07/08/2025
- Matthew Akers from Wells Fargo set a target price of $525.0 on 04/24/2025
- Ken Herbert from RBC Capital set a target price of $550.0 on 04/23/2025
- Michael Ciarmoli from Truist Securities set a target price of $550.0 on 04/23/2025
- Charles Minervino from Susquehanna set a target price of $540.0 on 04/23/2025
- Gavin Parsons from UBS set a target price of $571.0 on 04/23/2025
- Kristine Liwag from Morgan Stanley set a target price of $625.0 on 04/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
